Global Bio-chem Technology Group Company Limited
GBCMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,001 | $1,374 | $13 | $747 |
| % Growth | 45.6% | 10,709% | -98.3% | – |
| Cost of Goods Sold | $1,782 | $1,330 | $338 | $698 |
| Gross Profit | $219 | $44 | $8 | $48 |
| % Margin | 10.9% | 3.2% | 62.1% | 6.5% |
| R&D Expenses | $4 | $6 | $10 | $13 |
| G&A Expenses | $247 | $304 | $328 | $373 |
| SG&A Expenses | $354 | $370 | $268 | $436 |
| Sales & Mktg Exp. | $108 | $66 | $9 | $63 |
| Other Operating Expenses | $0 | -$6 | $0 | -$19 |
| Operating Expenses | $358 | $370 | $278 | $431 |
| Operating Income | -$140 | -$318 | -$270 | -$388 |
| % Margin | -7% | -23.2% | -2,122.9% | -52% |
| Other Income/Exp. Net | $885 | $4,019 | -$1,155 | -$22 |
| Pre-Tax Income | $746 | $3,701 | -$1,425 | -$409 |
| Tax Expense | -$24 | -$42 | -$47 | $26 |
| Net Income | $770 | $4,225 | -$1,443 | -$401 |
| % Margin | 38.5% | 307.5% | -11,352.9% | -53.7% |
| EPS | 4.3 | 23.5 | -8 | -2.25 |
| % Growth | -81.7% | 393.8% | -255.6% | – |
| EPS Diluted | 4.3 | 23.5 | -8 | -2.25 |
| Weighted Avg Shares Out | 179 | 178 | 178 | 178 |
| Weighted Avg Shares Out Dil | 179 | 178 | 178 | 178 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $323 | $750 | $685 | $791 |
| Depreciation & Amortization | $283 | $283 | $271 | $403 |
| EBITDA | $17 | -$43 | -$469 | $786 |
| % Margin | 0.8% | -3.2% | -3,690.2% | 105.2% |